Enzyme Inhibitors Market Global Trends, Analysis and Forecast 2027 Interstitial Lung Disease Treatment Market | Page 5

Interstitial Lung Disease Treatment Market
patients die each year from interstitial lung disease worldwide. The outlook for patients with interstitial
lung disease varies depending on the underlying cause of the disease. There is no absolute cure for
interstitial lung disease available as yet. A large portion of the treatment is directed to provide temporary
relieve to the patients. Failure to provide a complete cure and limited treatment options are considered
as major setbacks of the market. Limited drug options with low efficiency are further hindering the
growth of the global interstitial lung disease treatment market. UCSF has an active research program
conducting both clinical and basic research in the pathogenesis of lung fibrosis. Through the generosity of
patients, who collaborate with world-class physician scientists, they have developed a better
understanding of the fundamental, cellular and molecular mechanisms of interstitial lung disease. The
clinical research involves both observational studies and clinical trials that use the knowledge gained in
basic research to study the benefits of novel treatments in patients with lung fibrosis.\
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3261
Antibiotics may be given if a bacterial infection is responsible for the condition. Management of the
underlying disease process is also essential in a person with interstitial lung disease related to these
conditions. If the disease is thought to involve hypersensitivity, then the best therapy is avoidance of this
offending substance. Depending on the severity of the symptoms, respiratory support, including
supplemental oxygen and even ventilator support, may be required. Respiratory therapists may be part of
a treatment team with the goal of improving day to day function.
©2015 Future Market Insights, All Rights Reserved
5